---
title: "Gilead Sciences (GILD) Stock Outlook: Mizuho Lifts Target Amid Stronger Biktarvy Timeline"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/267937944.md"
description: "Mizuho increased its price target for Gilead Sciences (GILD) from $131 to $140, maintaining an Outperform rating due to a stronger Biktarvy timeline, with market exclusivity now expected until 2036. This positive outlook is tempered by the failure of Gilead's Trodelvy in a Phase 3 trial for metastatic breast cancer, though potential in the pre-exposure prophylaxis market for Yeztugo is noted."
datetime: "2025-11-29T18:32:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/267937944.md)
  - [en](https://longbridge.com/en/news/267937944.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/267937944.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/267937944.md) | [English](https://longbridge.com/en/news/267937944.md)


# Gilead Sciences (GILD) Stock Outlook: Mizuho Lifts Target Amid Stronger Biktarvy Timeline

Mizuho increased its price target for Gilead Sciences (GILD) from $131 to $140, maintaining an Outperform rating due to a stronger Biktarvy timeline, with market exclusivity now expected until 2036. This positive outlook is tempered by the failure of Gilead's Trodelvy in a Phase 3 trial for metastatic breast cancer, though potential in the pre-exposure prophylaxis market for Yeztugo is noted.

### 相關股票

- [Gilead Sciences (GILD.US)](https://longbridge.com/zh-HK/quote/GILD.US.md)

## 相關資訊與研究

- [$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today](https://longbridge.com/zh-HK/news/281058567.md)
- [Gilead Sciences Inc Stock (GILD) Moved Up by 3.62% on Mar 31: A Full Analysis](https://longbridge.com/zh-HK/news/281203982.md)
- [Galapagos, Gilead Enter Binding Agreement On Ouro Medicines Acquisition](https://longbridge.com/zh-HK/news/281128280.md)
- [BMS, Novartis, Gilead, Iovance dinged in CBER untitled letters](https://longbridge.com/zh-HK/news/281059389.md)
- [Handelsbanken Fonder AB Buys 69,440 Shares of Gilead Sciences, Inc. $GILD](https://longbridge.com/zh-HK/news/267025536.md)